Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol-Myers Squibb Company (BMY) Citi's 2024 Global Healthcare Conference (Transcript)
10:39am, Tuesday, 03'rd Dec 2024
Bristol-Myers Squibb Company (NYSE:BMY ) Citi's 2024 Global Healthcare Conference December 3, 2024 8:00 AM ET Company Participants Christopher Boerner - CEO and Board Chair David Elkins - EVP and CFO
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 03'rd Dec 2024
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
Is Bristol-Myers Squibb Stock a Millionaire Maker?
05:21am, Monday, 02'nd Dec 2024
Bristol-Myers Squibb (BMY -0.08%) is the kind of stock that potentially has a lot to offer to investors looking for wealth-building investments. With a large repertoire of medicines on the market, and
3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold Forever
06:11am, Friday, 29'th Nov 2024
Finding attractive dividend stocks you can hold isn't too difficult. Finding dividend stocks you can comfortably buy and hold forever is a different story.
Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney
02:00pm, Wednesday, 27'th Nov 2024
The Investment Committee debate the latest Calls of the Day.
BMY Stock vs. JNJ Stock
05:00am, Wednesday, 27'th Nov 2024
Given its better prospects, we believe that Bristol Myers Squibb stock (NYSE: BMY) is currently a better pharmaceutical pick over Johnson & Johnson stock (NYSE: JNJ). BMY stock trades at 8.3x its forw
Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference
06:59am, Tuesday, 26'th Nov 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference.
Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies
05:10am, Tuesday, 26'th Nov 2024
Prime Medicine's proprietary Prime Editing platform offers one-time therapeutic solutions, targeting over 90% of genetic conditions across multiple tissues and development stages. PRME's pipeline high
5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade)
03:47pm, Monday, 25'th Nov 2024
Bristol-Myers Squibb's price continues to rise due to a confluence of factors, not the least of which is an earnings surprise in Q3 2024. The company's raised guidance for 2024 is also encouraging, as
One Sector Has Underperformed Massively: These 4 Blue-Chip Dividend Giants Are Huge 2025 Plays
11:46am, Monday, 25'th Nov 2024
Key Points Donald Trump's victory is positive for the stock market.
Where Will Bristol Myers Squibb Be in 5 Years?
06:30am, Sunday, 24'th Nov 2024
Investors often look to major pharmaceutical stocks as an area that is likely to provide an anchor for their portfolios. Thanks to their supposedly consistent cash flows, they often appear to be capab
Potential $5,000 Monthly Income: 10 Investments To Buy And Hold For Next 10 Years
09:00am, Saturday, 23'rd Nov 2024
We present a highly diversified yet simple portfolio of 10 positions, with 9 funds and one individual MLP stock. The portfolio has been designed for retirees and investors planning for retirement, wit
Is Bristol Myers Squibb Stock a Buy?
08:00am, Thursday, 21'st Nov 2024
Is Bristol Myers Squibb Stock a Buy?
Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
04:33am, Thursday, 21'st Nov 2024
Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Wednesday, 20'th Nov 2024
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
